Grant number: 304215 | Funding period: 2022 - 2024
Completed
B Jayathilaka, F Mian, J Cockwill, F Franchini, G Au-Yeung, M IJzerman
2025-03-01
Background: Immune-related adverse events (irAE) pose challenges to the use of immune checkpoint inhibitors (ICI). While risk fact..
B Jayathilaka, F Mian, F Franchini, G Au-Yeung, M IJzerman
2025-01-31
Background: Immune-related adverse events (irAE) induced by immune checkpoint inhibitors (ICI) are a treatment-limiting barrier. T..
M Trommer, P Gillett, F Franchini, K Trapani, C Hornby, S Abraham, D Herath, K Gough, K Donohoe, P Tran, F Foroudi, M IJzerman, R Khor
2025-01-01
Background Palliative radiotherapy (PRT) is crucial for improving quality of life in patients with advanced-staged cancer. This la..